1. Azad Khan A.K., (1977): Lancet. An experiment to determine the active therapeutic moiety of sulphasalazine, ii, 892–895.
2. van Hees P.A.M., Bakker J.H., van Tongeren J.H.M., (1980): Gut. Effect of sulphapyridine, 5-aminosalicylic acid and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine,21, 632–635.
3. Campieri M., Lanfranchi G.A., Bazzocchi G., Brignola C, Sarti F., Franzin G., Battocchia A., Labo G., Dal Monte P.R., (1981): Lancet. Treatment of ulcerative colitis with high dose 5-aminosalicylic acid enemas,2, 270–271.
4. Klotz U., Maier K., Fischer C, Heinkel K., (1980): N. Eng. J. Med. Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn’s disease,303, 1499–1502.
5. Selby W.S., Barr G.D., Ireland A., Mason CH., Jewell D.P., (1985): Br. Medical J. Olsalazine in active ulcerative colitis,291, 1373–1375.